Invention Grant
- Patent Title: Methods of treating cardiovascular disorders with lectin-like oxidized LDL receptor 1 antibodies
-
Application No.: US15346026Application Date: 2016-11-08
-
Publication No.: US09982046B2Publication Date: 2018-05-29
- Inventor: Kurt Alex Heldwein , Igor Splawski , Jennifer Brogdon , Joshua Goldstein , William Dole , John Trauger , Chonghui Zhang
- Applicant: NOVARTIS AG
- Applicant Address: CH Basel
- Assignee: NOVARTIS AG
- Current Assignee: NOVARTIS AG
- Current Assignee Address: CH Basel
- Agent Sherwin Y. Chan
- Main IPC: A61P9/08
- IPC: A61P9/08 ; A61P9/04 ; A61P9/10 ; A61P9/12 ; A61K39/395 ; C07K16/28 ; A61K9/00 ; A61K45/06 ; C07K14/47 ; A61K39/00
Abstract:
The present invention relates to monoclonal antibodies binding to human lectin-like oxidized LDL (low density lipoprotein) receptor 1 (hereinafter, sometimes referred to as “LOX-1”), and pharmaceutical compositions and methods of treatment comprising the same.
Public/Granted literature
- US20170152313A1 LECTIN-LIKE OXIDIZED LDL RECEPTOR 1 ANTIBODIES AND METHODS OF USE Public/Granted day:2017-06-01
Information query
